Core Insights - Diversified Healthcare (DHC) reported quarterly funds from operations (FFO) of $0.09 per share, missing the Zacks Consensus Estimate of $0.12 per share, but showing an improvement from $0.02 per share a year ago [1] - The company experienced an FFO surprise of -25.00% for the quarter, and has only surpassed consensus FFO estimates once in the last four quarters [2] - Revenues for the quarter were $379.57 million, which was 4.53% below the Zacks Consensus Estimate, and slightly down from $379.62 million year-over-year [3] Financial Performance - The FFO for the last quarter was $0.09 per share, compared to an expected $0.12 per share, indicating a significant miss [1] - The company’s revenues of $379.57 million fell short of expectations, marking a slight decline from the previous year's revenues [3] - Over the last four quarters, the company has exceeded revenue estimates twice, indicating some variability in performance [3] Market Position and Outlook - Diversified Healthcare shares have increased by approximately 28.7% since the beginning of the year, outperforming the S&P 500, which gained only 0.9% [4] - The future performance of the stock will largely depend on management's commentary during the earnings call and the outlook for FFO [4][5] - The current consensus FFO estimate for the upcoming quarter is $0.14, with projected revenues of $395.44 million, and for the current fiscal year, the estimate is $0.57 on $1.61 billion in revenues [8] Industry Context - The REIT and Equity Trust - Other industry, to which Diversified Healthcare belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, which may impact stock performance [9] - Empirical research indicates a strong correlation between stock movements and estimate revisions, suggesting that investors should monitor these trends closely [6][7]

分组1 - EverQuote reported quarterly earnings of $1.54 per share, significantly exceeding the Zacks Consensus Estimate of $0.35 per share, representing an earnings surprise of +337.87% [1] - The company achieved revenues of $195.32 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 10.33%, compared to $147.46 million in the same quarter last year [2] - EverQuote has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed, losing about 42.6% since the beginning of the year, while the S&P 500 has gained 0.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.46 on revenues of $195.44 million, and for the current fiscal year, it is $1.77 on revenues of $774.18 million [7] - The Zacks Industry Rank indicates that the Internet - Software sector is currently in the bottom 47% of over 250 Zacks industries, which may impact stock performance [8]

分组1 - Helix Energy reported quarterly earnings of $0.16 per share, exceeding the Zacks Consensus Estimate of a loss of $0.02 per share, and showing an increase from earnings of $0.13 per share a year ago, resulting in an earnings surprise of +900.00% [1] - The company posted revenues of $334.16 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 12.28%, although this represents a decline from year-ago revenues of $355.13 million [2] - Helix Energy shares have increased by approximately 42.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $258.73 million, while for the current fiscal year, the estimate is $0.38 on revenues of $1.32 billion [7] - The Zacks Industry Rank for Oil and Gas - Field Services is in the top 31% of over 250 Zacks industries, indicating that companies in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]

分组1 - Ovintiv reported quarterly earnings of $1.39 per share, exceeding the Zacks Consensus Estimate of $0.98 per share, and showing an earnings surprise of +42.46% [1] - The company posted revenues of $2.15 billion for the quarter, surpassing the Zacks Consensus Estimate by 10.21%, although this is a slight decrease from $2.19 billion year-over-year [2] - Ovintiv shares have increased by approximately 29.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.92 on revenues of $1.98 billion, and for the current fiscal year, it is $3.79 on revenues of $8.37 billion [7] - The Zacks Industry Rank for Oil and Gas - Exploration and Production - Canadian is currently in the bottom 6% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Core Viewpoint - Brighthouse Financial reported quarterly earnings of $3.93 per share, missing the Zacks Consensus Estimate of $5.19 per share, and showing a decline from $5.88 per share a year ago, indicating a significant earnings surprise of -24.31% [1] Financial Performance - The company posted revenues of $2.17 billion for the quarter ended December 2025, which was 2.71% below the Zacks Consensus Estimate and a decrease from $2.27 billion in the same quarter last year [2] - Over the last four quarters, Brighthouse Financial has consistently failed to meet consensus EPS and revenue estimates [2] Stock Performance - Since the beginning of the year, Brighthouse Financial shares have decreased by approximately 1.3%, while the S&P 500 has gained 0.9% [3] - The stock currently holds a Zacks Rank of 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $5.04, with expected revenues of $2.25 billion, and for the current fiscal year, the consensus EPS is $20.56 on revenues of $8.97 billion [7] - The trend of estimate revisions for Brighthouse Financial has been unfavorable leading up to the earnings release [6] Industry Context - The Insurance - Life Insurance industry is currently ranked in the top 29% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom half of the rankings [8] - Another company in the same industry, Citizens, is expected to report quarterly earnings of $0.08 per share, reflecting a year-over-year increase of 14.3% [9]

分组1 - Primoris Services reported quarterly earnings of $1.08 per share, exceeding the Zacks Consensus Estimate of $0.95 per share, but down from $1.13 per share a year ago, resulting in an earnings surprise of +13.68% [1] - The company achieved revenues of $1.86 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 9.59% and increasing from $1.74 billion year-over-year [2] - Primoris Services has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 36.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.85 on revenues of $1.71 billion, and for the current fiscal year, it is $5.88 on revenues of $8.01 billion [7] - The Zacks Industry Rank for Building Products - Heavy Construction is in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

分组1 - Vir Biotechnology reported a quarterly loss of $0.31 per share, better than the Zacks Consensus Estimate of a loss of $0.42, and improved from a loss of $0.76 per share a year ago, resulting in an earnings surprise of +26.89% [1] - The company posted revenues of $64.07 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 243.23%, compared to year-ago revenues of $12.37 million [2] - Vir Biotechnology shares have increased by approximately 25.4% since the beginning of the year, outperforming the S&P 500's gain of 0.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.60 on revenues of $2.41 million, and for the current fiscal year, it is -$2.94 on revenues of $13.28 million [7] - The Medical - Biomedical and Genetics industry, to which Vir Biotechnology belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Viewpoint - Douglas Dynamics reported quarterly earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of $0.56 per share, and showing an increase from $0.39 per share a year ago, representing an earnings surprise of +10.71% [1] Financial Performance - The company achieved revenues of $184.54 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 6.67%, compared to $143.55 million in the same quarter last year [2] - Over the last four quarters, Douglas Dynamics has consistently surpassed consensus EPS estimates and revenue estimates [2] Stock Performance - Douglas Dynamics shares have increased approximately 31.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.9% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the next quarter is $0.06 on revenues of $131.7 million, and for the current fiscal year, it is $2.30 on revenues of $700.6 million [7] Industry Context - The Automotive - Replacement Parts industry, to which Douglas Dynamics belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, indicating potential challenges ahead [8]

Core Insights - Skyward Specialty Insurance (SKWD) reported a revenue of $385.59 million for Q4 2025, marking a year-over-year increase of 26.7% and exceeding the Zacks Consensus Estimate by 3.1% [1] - The earnings per share (EPS) for the same quarter was $1.17, compared to $0.80 a year ago, resulting in an EPS surprise of 21.56% against the consensus estimate of $0.96 [1] Financial Performance Metrics - Expense ratio stood at 28.9%, slightly above the six-analyst average estimate of 28.6% [4] - Loss ratio was reported at 59.6%, better than the average estimate of 62.6% [4] - Combined ratio was 88.5%, outperforming the six-analyst average estimate of 91.2% [4] - Net investment income was $23.51 million, exceeding the average estimate of $22.96 million, reflecting a year-over-year increase of 13.4% [4] - Commission and fee income was reported at $0.42 million, significantly lower than the average estimate of $1.57 million, indicating a year-over-year decline of 48.5% [4] - Net earned premiums reached $356.8 million, surpassing the average estimate of $349.51 million, with a year-over-year growth of 21.7% [4] Stock Performance - Skyward's shares have returned +4.4% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Performance - Ryman Hospitality Properties reported revenue of $737.81 million for the quarter ended December 2025, marking a year-over-year increase of 13.9% [1] - The earnings per share (EPS) for the same period was $2.38, compared to $1.13 a year ago, indicating significant growth [1] - The reported revenue exceeded the Zacks Consensus Estimate of $721.35 million by 2.28%, while the EPS surpassed the consensus estimate of $2.22 by 7.12% [1] Key Metrics - Total Revenue per Available Room (RevPAR) in the hospitality segment was $552.34, slightly above the average estimate of $550.06 from two analysts [4] - Entertainment revenues reached $109.53 million, exceeding the estimated $109.05 million by four analysts, reflecting an 11.6% increase compared to the previous year [4] - Hospitality revenues amounted to $628.28 million, surpassing the four-analyst average estimate of $614.63 million, with a year-over-year change of 14.4% [4] - Net Earnings Per Share (Diluted) was reported at $1.11, slightly above the estimated $1.10 from two analysts [4] Stock Performance - Ryman Hospitality Properties' shares have returned +9.8% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]